HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boschi, A. Articles by Giganti, M. Search for Related Content PubMed PubMed Citation Articles by Boschi, A. Articles by Giganti, M.

Synthesis and Biologic Evaluation of Monocationic Asymmetric ^99mTc-Nitride Heterocomplexes Showing High Heart Uptake and Improved Imaging Properties

¹ Laboratory of Nuclear Medicine, Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, Italy
² Department of Physics, University of Ferrara, Ferrara, Italy
³ Istituto di Chimica Inorganica e delle Superfici, Consiglio Nazionale delle Ricerche, Padua, Italy

The preparation, characterization, and first biologic evaluation in rats of a novel class of monocationic ^99mTc heart imaging agents are reported. The complexes are represented by the general formula [^99mTc(N)(PNP)(L)]⁺, where L is the monoanionic form of a dithiocarbamate ligand of the type [R¹(R²)-N-C(=S)S]^-, PNP is a diphosphine ligand of the type [(R³)₂P-(CH₂)₂]₂-N(R⁴), and R¹–R⁴ are organic functional groups. Methods: The new complexes were prepared by use of both liquid and freeze-dried formulations through a 2-step procedure. The first step involved the formation of the [Tc N]²⁺ group through the reaction of ^99mTcO₄^- with succinic dihydrazide as a donor of nitride nitrogen atoms (N^3-) in the presence of Sn²⁺ ions. This step was followed by the simultaneous addition to the reaction solution of the ligand PNP and of the sodium salt of the dithiocarbamate ligand (NaL) to afford the final products, [^99mTc(N)(PNP)(L)]⁺. The chemical identities of the resulting ^99mTc complexes were determined by comparing their chromatographic properties with those of the corresponding ^99gTc analogs prepared by use of the long-lived isotope ^99gTc and characterized by spectroscopic and crystallographic techniques. Ex vivo biodistribution studies were conducted in rats. In vivo tomographic images of the rat heart were obtained by use of a small-animal SPECT scanner. Results: The [^99mTc(N)(PNP)(L)]⁺ complexes are monocationic and possess a distorted square-pyramidal geometry in which the Tc N multiple bond occupies an apical position and the diphosphine and dithiocarbamate ligands span the residual 4 coordination positions on the basal plane through the 2 phosphorus atoms and the 2 sulfur atoms, respectively. Imaging and biodistribution studies demonstrated that these radiopharmaceuticals localize selectively in the myocardium of rats and are retained in this region for a prolonged time. The kinetics of heart uptake and clearance were found to be influenced by variations in the lateral R¹–R⁴ groups. Blood and lung washouts were extremely fast. Elimination occurred mostly through the kidneys and the liver. Surprisingly, at 1 h after injection, liver activity was almost negligible. Analysis of heart-to-liver and heart-to-lung uptake ratios showed that these values increased exponentially over time and became much higher than those determined for ^99mTc-sestamibi and ^99mTc-tetrofosmin. These findings were confirmed by analysis of high-quality SPECT images collected in rats for the new complexes and compared with images obtained with ^99mTc-sestamibi and ^99mTc-tetrofosmin. Conclusion: The high myocardial uptake and the very high heart-to-lung and heart-to-liver uptake ratios indicate that the [^99mTc(N)(PNP)(L)]⁺ complexes exhibit very favorable distribution properties and could be used to obtain SPECT cardiac images with improved quality.

Key Words: ^99mTc heart perfusion imaging agents • asymmetric ^99mTc-nitride heterocomplexes • mixed diphosphino-dithiocarbamate ^99mTc-nitride complexes

This article has been cited by other articles:

				C. Cittanti, L. Uccelli, M. Pasquali, A. Boschi, C. Flammia, E. Bagatin, M. Casali, M. G. Stabin, L. Feggi, M. Giganti, et al. Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC J. Nucl. Med., August 1, 2008; 49(8): 1299 - 1304. [Abstract] [Full Text] [PDF]

				C. Bolzati, M. Cavazza-Ceccato, S. Agostini, S. Tokunaga, D. Casara, and G. Bandoli Subcellular Distribution and Metabolism Studies of the Potential Myocardial Imaging Agent [99mTc(N)(DBODC)(PNP5)]+ J. Nucl. Med., August 1, 2008; 49(8): 1336 - 1344. [Abstract] [Full Text] [PDF]

				K. Hatada, L. M. Riou, M. Ruiz, Y. Yamamichi, A. Duatti, R. L. Lima, A. R. Goode, D. D. Watson, G. A. Beller, and D. K. Glover 99mTc-N-DBODC5, a New Myocardial Perfusion Imaging Agent with Rapid Liver Clearance: Comparison with 99mTc-Sestamibi and 99mTc-Tetrofosmin in Rats J. Nucl. Med., December 1, 2004; 45(12): 2095 - 2101. [Abstract] [Full Text] [PDF]